Volumina Medical as been selected, along with other 10 European start-ups, to receive 0.5 million euros from EIT Health.
EIT Health funding will speed up the development of Volumina Medical’s highly innovative scaffold, to address the problem of natural repair of 3D soft tissue for the market of reconstructive and plastic surgery.
EIT Health has awarded a total of 5.5 million euros to start-ups in Europe to support with business continuity in response to the disruptions caused by the COVID-19 pandemic. The Start-up Rescue Instrument was initiated by EIT Health in May and called on groundbreaking biotech, medtech and digital health start-ups to apply to receive up to 0.5 million euros in co-investment from EIT Health, in return for options.
To find out more about the EIT Health , please visit eithealth.eu